Company page
Puma Biotechnology Inc
Puma Biotechnology Inc (PBYI) is a public company operating in the American market, with a market capitalization of approximately $384.8 million. The company focuses on developing innovative therapies for cancer treatment. Puma's commitment to advancing oncology solutions positions it as a key player in the biopharmaceutical industry.
- Ticker
- PBYI:NASDAQ
- Asset type
- Stock
- Market cap
- $384.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD